{"data":{"profile":{"id":"d9c67122-d001-4363-b6e4-820130c01dd6","slug":"braidwell","displayName":"Braidwell","publicPageEnabled":true,"trackingTier":"FIRST_WAVE","isActive":true,"data":{"summary":"An investment manager focused on healthcare, life sciences, and computational biology.","strategyTags":["Healthcare","Life sciences","Computational biology"],"schemaVersion":1},"createdAt":"2026-07-18T23:28:04.697Z","updatedAt":"2026-07-21T17:30:06.695Z"},"managers":[{"id":"8c073638-a8e3-4cfc-bdd0-8b8c75b868f1","investorProfileId":"d9c67122-d001-4363-b6e4-820130c01dd6","cik":"0001920938","legalName":"BRAIDWELL LP","isActive":true,"data":{"sourceUrl":"https://data.sec.gov/submissions/CIK0001920938.json","schemaVersion":1},"firstTrackedAt":"2026-07-18T23:28:04.697Z","lastDiscoveryAt":"2026-07-21T17:30:01.310Z","createdAt":"2026-07-18T23:28:04.697Z","updatedAt":"2026-07-21T17:30:06.695Z"}],"snapshot":{"id":"3697bfc1-fa9d-4d46-9c1c-5bc39a6a9ea1","managerId":"8c073638-a8e3-4cfc-bdd0-8b8c75b868f1","reportPeriod":"2022-12-31","throughFilingId":"2bd3a66c-b0f6-4649-868a-ffab313c2907","methodologyVersion":"sec-13f-snapshot-v1","completeness":"COMPLETE","canonicalHash":"39507ac34bc59043c6835451b07acc0ba4ca39faedda4a374062d547943602e4","summary":{"counts":{"long":88,"puts":0,"calls":0,"mapped":0,"rawLines":90,"unmapped":88,"aiCovered":0,"positions":88,"otherSecurities":26},"values":{"disclosedLongUsd":"1687828199","putUnderlyingUsd":"0","callUnderlyingUsd":"0","informationTableUsd":"2984124707"},"coverage":{"aiPositionRatio":0,"aiLongValueRatio":0,"mappingPositionRatio":0,"mappingLongValueRatio":0},"warnings":["Form 13F is a delayed quarter-end disclosure and is not a current portfolio.","Options show reported underlying value, not premium paid, fund exposure, or manager intent.","AI sentiment is shown only for reviewed security mappings."],"concentration":{"top3":0.126826,"top5":0.204107,"top10":0.372712},"schemaVersion":1},"createdAt":"2026-07-19T00:01:04.794Z"},"filing":{"id":"2bd3a66c-b0f6-4649-868a-ffab313c2907","managerId":"8c073638-a8e3-4cfc-bdd0-8b8c75b868f1","ingestionRunId":"3f1795fc-80a1-4822-bb8c-f84b84d4d220","accessionNumber":"0001420506-23-000696","formType":"13F-HR","reportPeriod":"2022-12-31","filedAt":"2023-02-14","acceptedAt":"2023-02-14T21:27:48.000Z","processingStatus":"VALIDATED","sourceStatus":"ACTIVE","data":{"hashes":{"raw":"0a6b9830e975834a69d6d381c2eca98fefa8be61b752e0dfaa9bd97722f5b74d","canonical":"f73f9a9f12ba04b04f06addcd651cb0ad602dab7c76c619ef1c7c841850a5c46"},"source":{"directoryUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000142050623000696","filingDetailUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000142050623000696/0001420506-23-000696-index.html","coverDocumentUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000142050623000696/primary_doc.xml","informationTableUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000142050623000696/Form13F_InfoTable.xml","completeSubmissionUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000142050623000696/0001420506-23-000696.txt"},"parsing":{"parserVersion":"sec-13f-v1"},"summary":{"valueUnit":"USD","entryCount":90,"reportedValue":"2984124707","normalizedValueUsd":"2984124707"},"artifacts":[{"kind":"COVER_XML","byteSize":2512,"fetchedAt":"2026-07-19T00:01:04.346Z","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000142050623000696/primary_doc.xml","contentHash":"5cd82c114401ded13fd8a790bc83f9529d0c89bd220560f620576b03a7d20bf5","contentType":"text/xml","parserVersion":"sec-13f-v1"},{"kind":"INFORMATION_TABLE_XML","byteSize":42633,"fetchedAt":"2026-07-19T00:01:04.457Z","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000142050623000696/Form13F_InfoTable.xml","contentHash":"b5fe0a81f8b26a0bf86cd0066bf6516ee54e40f3168083a700550e4344da086c","contentType":"text/xml","parserVersion":"sec-13f-v1"},{"kind":"COMPLETE_SUBMISSION","byteSize":46427,"fetchedAt":"2026-07-19T00:01:04.511Z","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1920938/000142050623000696/0001420506-23-000696.txt","contentHash":"672663973ef7b45e3d02c0a27d7f2cf168fd9aeb9608b2b550404334e268045b","contentType":"text/plain","parserVersion":"sec-13f-v1"}],"extensions":{},"reportType":"HOLDINGS","schemaVersion":1,"includesHoldings":true,"hasConfidentialOmissions":false},"firstSeenAt":"2026-07-19T00:01:04.096Z","lastSeenAt":"2026-07-21T17:30:01.213Z","createdAt":"2026-07-19T00:01:04.096Z","updatedAt":"2026-07-21T17:30:01.213Z"},"positions":[{"id":"9dcf42c1-23bd-47e3-a3e9-cbc080da89cb","positionKey":"12c209fe-e802-4797-9dbe-ce134977d2f2:LONG","positionKind":"LONG","marketValueUsd":"156738792","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"250022000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"12c209fe-e802-4797-9dbe-ce134977d2f2","cusip":"40131MAB5","issuerName":"GUARDANT HEALTH INC","classTitle":"NOTE        11/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"fcdeae77-7186-41dc-a980-79ead03d7236","positionKey":"199bb8c6-90ef-4216-b328-31d8b0eb25bb:LONG","positionKind":"LONG","marketValueUsd":"118195691","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"145520000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"199bb8c6-90ef-4216-b328-31d8b0eb25bb","cusip":"63009RAD1","issuerName":"NANOSTRING TECHNOLOGIES INC","classTitle":"NOTE  2.625% 3/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"8149f9cb-a479-4e87-93e2-942385c900af","positionKey":"aa3120b5-75ff-4949-91c6-f111d576ce49:LONG","positionKind":"LONG","marketValueUsd":"117582745","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"131834000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"aa3120b5-75ff-4949-91c6-f111d576ce49","cusip":"67011XAB9","issuerName":"NOVOCURE LTD","classTitle":"NOTE        11/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"fa678411-c9b5-4aab-a904-9656b91caddf","positionKey":"b704fbdb-c374-4820-a86d-2f5a8bab754c:LONG","positionKind":"LONG","marketValueUsd":"109643200","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"139000000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"b704fbdb-c374-4820-a86d-2f5a8bab754c","cusip":"30063PAC9","issuerName":"EXACT SCIENCES CORP","classTitle":"NOTE  0.375% 3/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"fa504c2d-6199-47db-8261-f0d8ea649932","positionKey":"e3dfc330-4fce-44ec-917a-88a8fbd9881b:LONG","positionKind":"LONG","marketValueUsd":"103135300","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"112250000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"e3dfc330-4fce-44ec-917a-88a8fbd9881b","cusip":"02081GAB8","issuerName":"ALPHATEC HLDGS INC","classTitle":"NOTE  0.750% 8/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"feb9ff18-609c-4d1d-977a-df5d23b2a3fa","positionKey":"5eefa3aa-80b8-44ea-abf4-b5e28857aefa:LONG","positionKind":"LONG","marketValueUsd":"100237793","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"109251000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"5eefa3aa-80b8-44ea-abf4-b5e28857aefa","cusip":"64157FAC7","issuerName":"NEVRO CORP","classTitle":"NOTE  2.750% 4/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"4ef0bc60-746d-4906-b3a0-2086240eda8b","positionKey":"3b80261d-dd47-45ed-9596-8b2610ad493f:LONG","positionKind":"LONG","marketValueUsd":"72589652","longBookWeight":"0.04300772","sharesPrincipal":{"type":"SH","amount":"1661851"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"3b80261d-dd47-45ed-9596-8b2610ad493f","cusip":"377322102","issuerName":"GLAUKOS CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"3174caf8-4fad-416a-8bd0-03a0fa8b753a","positionKey":"6e57e1f9-6ee0-4502-8e45-7ff64d874141:LONG","positionKind":"LONG","marketValueUsd":"71537233","longBookWeight":"0.04238419","sharesPrincipal":{"type":"SH","amount":"3341300"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"6e57e1f9-6ee0-4502-8e45-7ff64d874141","cusip":"46583P102","issuerName":"IVERIC BIO INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"70385f03-27e7-4e1b-9a72-ad3223acfddd","positionKey":"c2d69bd9-b367-4933-bbe9-66ce60b49703:LONG","positionKind":"LONG","marketValueUsd":"69933931","longBookWeight":"0.04143427","sharesPrincipal":{"type":"SH","amount":"252542"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"c2d69bd9-b367-4933-bbe9-66ce60b49703","cusip":"09062X103","issuerName":"BIOGEN INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"7b868a0e-df1c-49ae-a250-81d4939d36ad","positionKey":"b4fa1262-cf37-4d35-a23c-d82623383d5a:LONG","positionKind":"LONG","marketValueUsd":"65321230","longBookWeight":"0.03870135","sharesPrincipal":{"type":"SH","amount":"1362278"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"b4fa1262-cf37-4d35-a23c-d82623383d5a","cusip":"92243G108","issuerName":"VAXCYTE INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"08d44e2c-ed15-4855-a3ef-f5f9b847452d","positionKey":"bd844f72-d93c-498f-a06d-a50bbcb37f53:LONG","positionKind":"LONG","marketValueUsd":"65116052","longBookWeight":"0.03857978","sharesPrincipal":{"type":"SH","amount":"1621012"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"bd844f72-d93c-498f-a06d-a50bbcb37f53","cusip":"632307104","issuerName":"NATERA INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"d701f3e8-32ac-4085-9bbe-ecf72a869ba9","positionKey":"3c94594e-7d65-46d7-aac9-8b407c820f61:LONG","positionKind":"LONG","marketValueUsd":"63675000","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"141500000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"3c94594e-7d65-46d7-aac9-8b407c820f61","cusip":"10806XAB8","issuerName":"BRIDGEBIO PHARMA INC","classTitle":"NOTE  2.500% 3/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"0f4618b0-25b0-45b5-ada8-dc6296c5d2f3","positionKey":"d9b022c6-6b9a-42b5-846f-00b0cf9ecf05:LONG","positionKind":"LONG","marketValueUsd":"63495034","longBookWeight":"0.03761937","sharesPrincipal":{"type":"SH","amount":"3469674"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"d9b022c6-6b9a-42b5-846f-00b0cf9ecf05","cusip":"22663K107","issuerName":"CRINETICS PHARMACEUTICALS IN","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b1442707-2315-41dd-9820-0fd4b7f192d6","positionKey":"0bd65fc1-b8f0-4667-bf30-1532f51979dc:LONG","positionKind":"LONG","marketValueUsd":"61041977","longBookWeight":"0.03616598","sharesPrincipal":{"type":"SH","amount":"1548110"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"0bd65fc1-b8f0-4667-bf30-1532f51979dc","cusip":"98420N105","issuerName":"XENON PHARMACEUTICALS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"de151685-385e-4b8c-bcb5-747341a62aed","positionKey":"9c1e8170-8764-49c2-80bc-cb7673e6af38:LONG","positionKind":"LONG","marketValueUsd":"59204892","longBookWeight":"0.03507755","sharesPrincipal":{"type":"SH","amount":"223120"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"9c1e8170-8764-49c2-80bc-cb7673e6af38","cusip":"46120E602","issuerName":"INTUITIVE SURGICAL INC","classTitle":"COM NEW","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"f450b726-11b1-48b5-93d9-cf10e6d28d82","positionKey":"bd109cde-996a-44b8-933d-20e79866f087:LONG","positionKind":"LONG","marketValueUsd":"53620098","longBookWeight":"0.03176869","sharesPrincipal":{"type":"SH","amount":"3271513"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"bd109cde-996a-44b8-933d-20e79866f087","cusip":"24344T101","issuerName":"DECIPHERA PHARMACEUTICALS IN","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"d6f1b482-bb86-4c70-a2c8-02436a7ac574","positionKey":"314593c8-19ad-4c08-b205-619fa6811423:LONG","positionKind":"LONG","marketValueUsd":"49369841","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"65976000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"314593c8-19ad-4c08-b205-619fa6811423","cusip":"48576UAA4","issuerName":"KARYOPHARM THERAPEUTICS INC","classTitle":"NOTE  3.000%10/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"832476fe-2b6e-4304-91a7-754c2ab280bf","positionKey":"fabba85f-b203-45f7-a10f-24ddec0ab73c:LONG","positionKind":"LONG","marketValueUsd":"48949313","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"52740000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"fabba85f-b203-45f7-a10f-24ddec0ab73c","cusip":"462222AD2","issuerName":"IONIS PHARMACEUTICALS INC","classTitle":"NOTE         4/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"ca6d15c0-18a8-4126-82ee-4f2f43181aef","positionKey":"f3a07db7-653f-48c5-89a4-52689d2b2710:LONG","positionKind":"LONG","marketValueUsd":"47215001","longBookWeight":"0.02797381","sharesPrincipal":{"type":"SH","amount":"1192298"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"f3a07db7-653f-48c5-89a4-52689d2b2710","cusip":"64157F103","issuerName":"NEVRO CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"d3c812a7-171b-477e-b31d-7134b13d5fe7","positionKey":"a8790a3c-15be-434d-b329-6f88747ee17d:LONG","positionKind":"LONG","marketValueUsd":"46649782","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"50536000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"a8790a3c-15be-434d-b329-6f88747ee17d","cusip":"761299AB2","issuerName":"TRAVERE THERAPEUTICS INC","classTitle":"NOTE  2.500% 9/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"cf880f68-0ed3-4661-a7b2-211802e8f2b0","positionKey":"ce4d1411-016f-4708-bda9-73ddac8af95b:LONG","positionKind":"LONG","marketValueUsd":"46616468","longBookWeight":"0.02761920","sharesPrincipal":{"type":"SH","amount":"497667"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"ce4d1411-016f-4708-bda9-73ddac8af95b","cusip":"450056106","issuerName":"IRHYTHM HOLDINGS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b4e1ee50-8bf1-408d-b17a-21f20ea3bb59","positionKey":"4a96d730-67e2-42e8-960b-acd08f02707e:LONG","positionKind":"LONG","marketValueUsd":"46383237","longBookWeight":"0.02748101","sharesPrincipal":{"type":"SH","amount":"219930"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"4a96d730-67e2-42e8-960b-acd08f02707e","cusip":"016255101","issuerName":"ALIGN TECHNOLOGY INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b881bec6-cd7e-46ee-be3a-a5acffe8c0ac","positionKey":"d7aeb20d-986c-4e70-8d15-d9b227377e9d:LONG","positionKind":"LONG","marketValueUsd":"44011533","longBookWeight":"0.02607583","sharesPrincipal":{"type":"SH","amount":"1704552"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"d7aeb20d-986c-4e70-8d15-d9b227377e9d","cusip":"690145107","issuerName":"OUTSET MED INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"41d6e39e-9751-411c-a29e-44bd73880949","positionKey":"3c646c5a-8507-4ded-817f-d7aae9d153c4:LONG","positionKind":"LONG","marketValueUsd":"43250438","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"137850000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"3c646c5a-8507-4ded-817f-d7aae9d153c4","cusip":"03236MAJ0","issuerName":"AMYRIS INC","classTitle":"NOTE  1.500%11/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"eac66476-2db3-4b83-a710-93c7c1b7da96","positionKey":"9eaf5462-bf8c-4e86-8f14-57c20df6bae8:LONG","positionKind":"LONG","marketValueUsd":"41505891","longBookWeight":"0.02459130","sharesPrincipal":{"type":"SH","amount":"1044699"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"9eaf5462-bf8c-4e86-8f14-57c20df6bae8","cusip":"68752L100","issuerName":"ORTHOPEDIATRICS CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"081de374-2bfd-4368-9390-afcc89fd9ccd","positionKey":"7b0d725f-da38-4ee9-abfc-8d3f7a19a1a4:LONG","positionKind":"LONG","marketValueUsd":"40089000","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"48300000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"7b0d725f-da38-4ee9-abfc-8d3f7a19a1a4","cusip":"30063PAB1","issuerName":"EXACT SCIENCES CORP","classTitle":"NOTE  0.375% 3/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"8795bbce-86f3-4f03-9c03-a1c48ede70e1","positionKey":"ce2bb017-ea61-4160-a6f1-90aa258c80bc:LONG","positionKind":"LONG","marketValueUsd":"37705264","longBookWeight":"0.02233951","sharesPrincipal":{"type":"SH","amount":"2393985"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"ce2bb017-ea61-4160-a6f1-90aa258c80bc","cusip":"00461U105","issuerName":"ACLARIS THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"cb6c2c6c-c04f-4e71-9085-f18c65b83180","positionKey":"20d1510a-f4f7-4e8f-9df7-fe9b20f05511:LONG","positionKind":"LONG","marketValueUsd":"37665128","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"399630000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"20d1510a-f4f7-4e8f-9df7-fe9b20f05511","cusip":"457669AA7","issuerName":"INSMED INC","classTitle":"NOTE  1.750% 1/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"8ef50824-5e3d-4281-bb59-a1af71013685","positionKey":"4cebd372-f885-4124-aa5b-1db39ef3a985:LONG","positionKind":"LONG","marketValueUsd":"36469375","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"43000000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"4cebd372-f885-4124-aa5b-1db39ef3a985","cusip":"64049MAA8","issuerName":"NEOGENOMICS INC","classTitle":"NOTE  1.250% 5/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"4306ba42-de81-46be-9650-67db78c1e89e","positionKey":"f4fd6fb7-262a-4dfe-b739-4256f4ce0a6e:LONG","positionKind":"LONG","marketValueUsd":"36222717","longBookWeight":"0.02146113","sharesPrincipal":{"type":"SH","amount":"162828"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"f4fd6fb7-262a-4dfe-b739-4256f4ce0a6e","cusip":"70975L107","issuerName":"PENUMBRA INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"2d348d85-5877-4d53-8ee8-bdbeb324622e","positionKey":"60d83db2-8cb1-44ce-bf3a-85793686eac1:LONG","positionKind":"LONG","marketValueUsd":"34432104","longBookWeight":"0.02040024","sharesPrincipal":{"type":"SH","amount":"131100"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"60d83db2-8cb1-44ce-bf3a-85793686eac1","cusip":"031162100","issuerName":"AMGEN INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"8d6b540d-f2c5-488e-8845-7180772b0076","positionKey":"f9ea9ff4-ec04-4394-bc37-34b3faef3130:LONG","positionKind":"LONG","marketValueUsd":"33804701","longBookWeight":"0.02002852","sharesPrincipal":{"type":"SH","amount":"4112494"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"f9ea9ff4-ec04-4394-bc37-34b3faef3130","cusip":"07987C204","issuerName":"BELLUS HEALTH INC NEW","classTitle":"COM NEW","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b2617d22-8a91-4ea8-b72c-7f411eb900b1","positionKey":"4e12d220-bd73-4c68-948a-f50c07a00b53:LONG","positionKind":"LONG","marketValueUsd":"33358282","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"36533000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"4e12d220-bd73-4c68-948a-f50c07a00b53","cusip":"462222AB6","issuerName":"IONIS PHARMACEUTICALS INC","classTitle":"NOTE  0.125%12/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"599f127e-9c99-4053-976b-05874f52bda0","positionKey":"b7a0ab4d-df6c-4c26-9db1-b6124ee1d833:LONG","positionKind":"LONG","marketValueUsd":"32852402","longBookWeight":"0.01946430","sharesPrincipal":{"type":"SH","amount":"658101"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"b7a0ab4d-df6c-4c26-9db1-b6124ee1d833","cusip":"52490G102","issuerName":"LEGEND BIOTECH CORP","classTitle":"SPONSORED ADS","securityType":"ADR","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"ee7764b4-7b44-4fa9-99b6-f8324d688788","positionKey":"84fb0bc0-691b-4c28-835c-93ebd221af9c:LONG","positionKind":"LONG","marketValueUsd":"32210203","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"36665000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"84fb0bc0-691b-4c28-835c-93ebd221af9c","cusip":"670704AJ4","issuerName":"NUVASIVE INC","classTitle":"NOTE  0.375% 3/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"ec753460-c805-4d68-8915-6fe53c7ac455","positionKey":"3fcec05f-9ecd-4786-9c91-3d9d2709a11a:LONG","positionKind":"LONG","marketValueUsd":"31947371","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"48678000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"3fcec05f-9ecd-4786-9c91-3d9d2709a11a","cusip":"64049MAB6","issuerName":"NEOGENOMICS INC","classTitle":"NOTE  0.250% 1/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"93218b23-630b-4ec2-af29-d0f5ac7f29bd","positionKey":"e8c9aff6-3694-48cc-8793-b246ee7c0946:LONG","positionKind":"LONG","marketValueUsd":"31629311","longBookWeight":"0.01873965","sharesPrincipal":{"type":"SH","amount":"1242802"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"e8c9aff6-3694-48cc-8793-b246ee7c0946","cusip":"87164F105","issuerName":"SYNDAX PHARMACEUTICALS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"48503425-9a3e-492a-95f7-26559d43ba3a","positionKey":"d47e6fb1-8923-4f9f-bb53-03276e79b546:LONG","positionKind":"LONG","marketValueUsd":"30910360","longBookWeight":"0.01831368","sharesPrincipal":{"type":"SH","amount":"1998084"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"d47e6fb1-8923-4f9f-bb53-03276e79b546","cusip":"N5749R100","issuerName":"MERUS N V","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"02e065cc-c2c9-4217-bd56-641abda72603","positionKey":"c3ec4691-9a17-421f-86ad-b6a03768d3db:LONG","positionKind":"LONG","marketValueUsd":"30610953","longBookWeight":"0.01813629","sharesPrincipal":{"type":"SH","amount":"1455585"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"c3ec4691-9a17-421f-86ad-b6a03768d3db","cusip":"89422G107","issuerName":"TRAVERE THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"22a0988b-e7cb-41aa-95f6-c2ec5fa729d7","positionKey":"1f41ec34-c819-464a-8706-f299912ed4b7:LONG","positionKind":"LONG","marketValueUsd":"28685250","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"31350000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"1f41ec34-c819-464a-8706-f299912ed4b7","cusip":"89422GAA5","issuerName":"TRAVERE THERAPEUTICS INC","classTitle":"NOTE  2.250% 3/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"91411f36-8f53-41f2-9058-0c3db0706a49","positionKey":"ad617f3e-e731-4609-8a18-599a7368d09c:LONG","positionKind":"LONG","marketValueUsd":"28365196","longBookWeight":"0.01680573","sharesPrincipal":{"type":"SH","amount":"358056"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"ad617f3e-e731-4609-8a18-599a7368d09c","cusip":"501147102","issuerName":"KRYSTAL BIOTECH INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"1fe5f0c1-71af-4ea1-9fcb-8394bbfa3209","positionKey":"1de6929f-c603-4754-9487-48567a2998a0:LONG","positionKind":"LONG","marketValueUsd":"27106214","longBookWeight":"0.01605981","sharesPrincipal":{"type":"SH","amount":"1620216"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"1de6929f-c603-4754-9487-48567a2998a0","cusip":"43157M102","issuerName":"HILLEVAX INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"0ede1ea5-1f5b-42fa-a46f-f4d7875181fb","positionKey":"070ddc7f-1434-41b8-8afe-56aa34dcd284:LONG","positionKind":"LONG","marketValueUsd":"26825519","longBookWeight":"0.01589351","sharesPrincipal":{"type":"SH","amount":"1246539"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"070ddc7f-1434-41b8-8afe-56aa34dcd284","cusip":"23954D109","issuerName":"DAY ONE BIOPHARMACEUTICALS I","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"c6395ede-cf62-4fb3-a4f9-f09987e79525","positionKey":"b3f1ef99-6223-48c2-8f45-98079060afa3:LONG","positionKind":"LONG","marketValueUsd":"26179140","longBookWeight":"0.01551054","sharesPrincipal":{"type":"SH","amount":"839075"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"b3f1ef99-6223-48c2-8f45-98079060afa3","cusip":"23345J104","issuerName":"DICE THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"7aa4fc41-4c37-4d80-986a-a1570d776e61","positionKey":"c9526a61-91a3-4a6e-b102-3494ac22463d:LONG","positionKind":"LONG","marketValueUsd":"25738438","longBookWeight":"0.01524944","sharesPrincipal":{"type":"SH","amount":"300437"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"c9526a61-91a3-4a6e-b102-3494ac22463d","cusip":"219798105","issuerName":"QUIDELORTHO CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"6a469d98-2e38-448c-ba81-34f0737399f4","positionKey":"b4236abc-23e5-4015-9067-1b2372e5e030:LONG","positionKind":"LONG","marketValueUsd":"25521103","longBookWeight":"0.01512067","sharesPrincipal":{"type":"SH","amount":"343626"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"b4236abc-23e5-4015-9067-1b2372e5e030","cusip":"379577208","issuerName":"GLOBUS MED INC","classTitle":"CL A","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"cad75614-8830-4831-b6b9-c5eff5a50d23","positionKey":"cb03d580-f5ea-455c-bd94-6f40053fd988:LONG","positionKind":"LONG","marketValueUsd":"23770486","longBookWeight":"0.01408347","sharesPrincipal":{"type":"SH","amount":"1493121"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"cb03d580-f5ea-455c-bd94-6f40053fd988","cusip":"004225108","issuerName":"ACADIA PHARMACEUTICALS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"a71148d5-679b-4c9d-9345-df268bf7131b","positionKey":"a3a58000-e26a-459d-b102-54e3ddc3ea9d:LONG","positionKind":"LONG","marketValueUsd":"22502521","longBookWeight":"0.01333223","sharesPrincipal":{"type":"SH","amount":"726122"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"a3a58000-e26a-459d-b102-54e3ddc3ea9d","cusip":"032724106","issuerName":"ANAPTYSBIO INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"0475a33b-1a8f-4175-bcd7-06ab411f4d78","positionKey":"c7644675-18e1-4710-b6ee-cc7187904889:LONG","positionKind":"LONG","marketValueUsd":"22028779","longBookWeight":"0.01305155","sharesPrincipal":{"type":"SH","amount":"416817"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"c7644675-18e1-4710-b6ee-cc7187904889","cusip":"82710M100","issuerName":"SILK RD MED INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"50ea3d20-042a-441c-910c-b8bb1b2665df","positionKey":"6b13c388-df23-48c8-98cb-202d7adcd321:LONG","positionKind":"LONG","marketValueUsd":"21140913","longBookWeight":"0.01252551","sharesPrincipal":{"type":"SH","amount":"3393405"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"6b13c388-df23-48c8-98cb-202d7adcd321","cusip":"29664W105","issuerName":"ESPERION THERAPEUTICS INC NE","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"603adbcd-46de-4a9a-b811-628befce1e0d","positionKey":"bdb5af6f-2ee1-4e3f-b4c4-4ce5892ad7e4:LONG","positionKind":"LONG","marketValueUsd":"20727568","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"19200000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"bdb5af6f-2ee1-4e3f-b4c4-4ce5892ad7e4","cusip":"09061GAK7","issuerName":"BIOMARIN PHARMACEUTICAL INC","classTitle":"NOTE  1.250% 5/1","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"6974baaf-f0f9-43c0-80ef-b5bd1110de15","positionKey":"e65f40dd-85cf-47cb-a4ad-fabb7c80a779:LONG","positionKind":"LONG","marketValueUsd":"20146009","longBookWeight":"0.01193605","sharesPrincipal":{"type":"SH","amount":"389596"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"e65f40dd-85cf-47cb-a4ad-fabb7c80a779","cusip":"03753U106","issuerName":"APELLIS PHARMACEUTICALS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b8fa1b6c-cc28-4160-bd90-b6dbb029ce5e","positionKey":"cf297024-d08e-4bb2-a654-5bb9b3a781da:LONG","positionKind":"LONG","marketValueUsd":"19800000","longBookWeight":"0.01173105","sharesPrincipal":{"type":"SH","amount":"1000000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"cf297024-d08e-4bb2-a654-5bb9b3a781da","cusip":"75382E109","issuerName":"RAPT THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"4acf7c32-a444-4360-a52e-e982458ed5d9","positionKey":"0199db3e-152b-4e28-9974-cc6b39b8b317:LONG","positionKind":"LONG","marketValueUsd":"18740216","longBookWeight":"0.01110315","sharesPrincipal":{"type":"SH","amount":"413600"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"0199db3e-152b-4e28-9974-cc6b39b8b317","cusip":"60468T105","issuerName":"MIRATI THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"849fc6b8-cc3e-4610-ac64-718891af32fc","positionKey":"be6f098c-1bdf-4dd8-a3e4-2ae6914a0195:LONG","positionKind":"LONG","marketValueUsd":"18712578","longBookWeight":"0.01108677","sharesPrincipal":{"type":"SH","amount":"303185"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"be6f098c-1bdf-4dd8-a3e4-2ae6914a0195","cusip":"89377M109","issuerName":"TRANSMEDICS GROUP INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"2ff71ff5-3cba-4003-8798-7578c8b735d1","positionKey":"ea5218a3-0cdd-435c-89b0-7e6030705dc8:LONG","positionKind":"LONG","marketValueUsd":"18638436","longBookWeight":"0.01104285","sharesPrincipal":{"type":"SH","amount":"49200"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"ea5218a3-0cdd-435c-89b0-7e6030705dc8","cusip":"04016X101","issuerName":"ARGENX SE","classTitle":"SPONSORED ADR","securityType":"ADR","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"f1c9f24c-02b5-4040-b25b-4705767cc24f","positionKey":"09b7e7d7-fbdd-4085-91dc-9b0a5ff5013c:LONG","positionKind":"LONG","marketValueUsd":"18524911","longBookWeight":"0.01097559","sharesPrincipal":{"type":"SH","amount":"12107785"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"09b7e7d7-fbdd-4085-91dc-9b0a5ff5013c","cusip":"23306J101","issuerName":"DBV TECHNOLOGIES S A","classTitle":"SPONSORED ADR","securityType":"ADR","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"926888a5-ac16-4dd2-9acc-6c3fe98e4191","positionKey":"d6512c87-6964-4086-bec8-0077739bc253:LONG","positionKind":"LONG","marketValueUsd":"18186812","longBookWeight":"0.01077527","sharesPrincipal":{"type":"SH","amount":"140352"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"d6512c87-6964-4086-bec8-0077739bc253","cusip":"803607100","issuerName":"SAREPTA THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"a0d950ee-3b6b-4345-93aa-db712ab3416d","positionKey":"c17c190b-d314-4f53-a637-e9a628839776:LONG","positionKind":"LONG","marketValueUsd":"18015893","longBookWeight":"0.01067400","sharesPrincipal":{"type":"SH","amount":"662349"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"c17c190b-d314-4f53-a637-e9a628839776","cusip":"76029N106","issuerName":"REPLIMUNE GROUP INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"c053d87b-da11-44ed-a312-c947a4a080b6","positionKey":"0556dd4c-7474-4177-9544-aff41211b02e:LONG","positionKind":"LONG","marketValueUsd":"17673725","longBookWeight":"0.01047128","sharesPrincipal":{"type":"SH","amount":"95694"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"0556dd4c-7474-4177-9544-aff41211b02e","cusip":"G8473T100","issuerName":"STERIS PLC","classTitle":"SHS USD","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"1e8dae78-058e-4df1-9f92-11b7ff5f8a8e","positionKey":"cf506ced-b70c-4c31-9ac3-76b04e70d204:LONG","positionKind":"LONG","marketValueUsd":"17557151","longBookWeight":"0.01040221","sharesPrincipal":{"type":"SH","amount":"235319"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"cf506ced-b70c-4c31-9ac3-76b04e70d204","cusip":"28176E108","issuerName":"EDWARDS LIFESCIENCES CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"0e670191-6d2b-4643-a2a9-4aceae8f599e","positionKey":"fc1411eb-f3f5-4279-917b-dace5c3958b9:LONG","positionKind":"LONG","marketValueUsd":"17233505","longBookWeight":"0.01021046","sharesPrincipal":{"type":"SH","amount":"3474497"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"fc1411eb-f3f5-4279-917b-dace5c3958b9","cusip":"45253H101","issuerName":"IMMUNOGEN INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"a7a9b1a9-764e-4db9-9021-72692baf6165","positionKey":"7add00dd-240d-4acb-a762-e163d9f0a732:LONG","positionKind":"LONG","marketValueUsd":"17232867","longBookWeight":"0.01021008","sharesPrincipal":{"type":"SH","amount":"52115"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"7add00dd-240d-4acb-a762-e163d9f0a732","cusip":"216648402","issuerName":"COOPER COS INC","classTitle":"COM NEW","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"50c85638-b371-477f-89b9-d69bbb41c1ac","positionKey":"43fed5e1-6743-46df-92b8-f9e6fe5e04fa:LONG","positionKind":"LONG","marketValueUsd":"17038830","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"21500000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"43fed5e1-6743-46df-92b8-f9e6fe5e04fa","cusip":"46185LAB9","issuerName":"INVITAE CORP","classTitle":"NOTE  2.000% 9/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b91d1206-c841-4f5e-af2e-768269611696","positionKey":"9cda1154-b008-42ee-a1e0-3e6316f44e45:LONG","positionKind":"LONG","marketValueUsd":"16231875","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"16500000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"9cda1154-b008-42ee-a1e0-3e6316f44e45","cusip":"670704AL9","issuerName":"NUVASIVE INC","classTitle":"NOTE  1.000% 6/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"a72bc99e-321e-4e7e-9fa3-17173204fc17","positionKey":"a574bde3-483c-475d-87d0-b6b4bfcaab2d:LONG","positionKind":"LONG","marketValueUsd":"16151021","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"42294000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"a574bde3-483c-475d-87d0-b6b4bfcaab2d","cusip":"10806XAD4","issuerName":"BRIDGEBIO PHARMA INC","classTitle":"NOTE  2.250% 2/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"b835e48c-8468-4f39-a801-329398a39911","positionKey":"c4d370b0-4899-4c39-8447-7f44cc9918f3:LONG","positionKind":"LONG","marketValueUsd":"15157984","longBookWeight":"0.00898076","sharesPrincipal":{"type":"SH","amount":"325838"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"c4d370b0-4899-4c39-8447-7f44cc9918f3","cusip":"29251M106","issuerName":"ENANTA PHARMACEUTICALS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"a6f1fbe1-e0fd-4d66-ac30-617305a03f05","positionKey":"073a24f2-cc87-4d82-8fc2-553e340bafc1:LONG","positionKind":"LONG","marketValueUsd":"13669194","longBookWeight":"0.00809868","sharesPrincipal":{"type":"SH","amount":"1621494"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"073a24f2-cc87-4d82-8fc2-553e340bafc1","cusip":"745848101","issuerName":"PULMONX CORP","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"511f7e5f-9c7a-4e43-82e4-620546382a75","positionKey":"43e8577e-3e65-4bef-9d9f-076336523cc6:LONG","positionKind":"LONG","marketValueUsd":"10915422","longBookWeight":"0.00646714","sharesPrincipal":{"type":"SH","amount":"1862700"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"43e8577e-3e65-4bef-9d9f-076336523cc6","cusip":"59045L106","issuerName":"MERSANA THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"17c39522-b6cd-4bff-b90f-9280955a2c4c","positionKey":"8f1dd51a-92d8-4d9c-86d2-0b6b054213a8:LONG","positionKind":"LONG","marketValueUsd":"10887953","longBookWeight":"0.00645086","sharesPrincipal":{"type":"SH","amount":"1250052"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"8f1dd51a-92d8-4d9c-86d2-0b6b054213a8","cusip":"N44445109","issuerName":"IMMATICS N.V","classTitle":"SHS","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"e213b55b-c28c-471a-8488-68ff05fcbe30","positionKey":"10f1a094-b976-457a-a10a-abb4b5d95c44:LONG","positionKind":"LONG","marketValueUsd":"10122298","longBookWeight":"0.00599723","sharesPrincipal":{"type":"SH","amount":"927800"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"10f1a094-b976-457a-a10a-abb4b5d95c44","cusip":"74366E102","issuerName":"PROTAGONIST THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"e506f767-c3cd-412f-b8be-85247ef97e1b","positionKey":"8eacdc14-2dfa-4e5b-829f-284890b4c8c1:LONG","positionKind":"LONG","marketValueUsd":"9574200","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"9000000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"8eacdc14-2dfa-4e5b-829f-284890b4c8c1","cusip":"09061GAH4","issuerName":"BIOMARIN PHARMACEUTICAL INC","classTitle":"NOTE  0.599% 8/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"d100816e-b8d2-449e-b0a2-cfb8c042d2f3","positionKey":"2a7b761e-af14-4b20-8a17-9466ad7367b1:LONG","positionKind":"LONG","marketValueUsd":"9154502","longBookWeight":"0.00542383","sharesPrincipal":{"type":"SH","amount":"313403"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"2a7b761e-af14-4b20-8a17-9466ad7367b1","cusip":"92790C104","issuerName":"VIRIDIAN THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"e7722bdc-a4ec-44e4-8323-4f79d8980df2","positionKey":"8d7f6c43-f846-40dd-91a8-1e5da4bcf984:LONG","positionKind":"LONG","marketValueUsd":"9139542","longBookWeight":"0.00541497","sharesPrincipal":{"type":"SH","amount":"1525800"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"8d7f6c43-f846-40dd-91a8-1e5da4bcf984","cusip":"65487U108","issuerName":"NKARTA INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"5c40c75f-531d-4026-b013-d96fada9c117","positionKey":"5f8e2866-ec8f-4e2a-b742-5d36751c254a:LONG","positionKind":"LONG","marketValueUsd":"9125758","longBookWeight":"0.00540680","sharesPrincipal":{"type":"SH","amount":"1814266"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"5f8e2866-ec8f-4e2a-b742-5d36751c254a","cusip":"20454B104","issuerName":"COMPASS THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"0d554ac6-fb8b-4b24-93b0-09bb30ac8c4b","positionKey":"d20b5c11-cc66-4cdc-b4a1-3b577db76edd:LONG","positionKind":"LONG","marketValueUsd":"8728951","longBookWeight":"0.00517170","sharesPrincipal":{"type":"SH","amount":"753145"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"d20b5c11-cc66-4cdc-b4a1-3b577db76edd","cusip":"26818M108","issuerName":"DYNE THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"79f8ae25-ca34-4821-a056-7aa6035f6d2f","positionKey":"4499e55b-e777-4428-9f91-65f96c12beb3:LONG","positionKind":"LONG","marketValueUsd":"8300000","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"10000000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"4499e55b-e777-4428-9f91-65f96c12beb3","cusip":"457669AB5","issuerName":"INSMED INC","classTitle":"NOTE  0.750% 6/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"8cb8584c-d99c-4bfb-84b7-3f608efabc1d","positionKey":"ac17fe62-c628-4ea7-85c9-01584d2d2bcd:LONG","positionKind":"LONG","marketValueUsd":"7915968","longBookWeight":"0.00469003","sharesPrincipal":{"type":"SH","amount":"4122900"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"ac17fe62-c628-4ea7-85c9-01584d2d2bcd","cusip":"67080N101","issuerName":"NUVATION BIO INC","classTitle":"COM CL A","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"ad145c2b-3b76-4b1b-9adb-36514ce576e2","positionKey":"e5d6ea7d-0ef3-4759-a3bb-bbd83cd13198:LONG","positionKind":"LONG","marketValueUsd":"7748960","longBookWeight":"0.00459108","sharesPrincipal":{"type":"SH","amount":"920304"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"e5d6ea7d-0ef3-4759-a3bb-bbd83cd13198","cusip":"01671P100","issuerName":"ALLAKOS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"9a241db5-2e00-45b2-873a-c5bc098290f7","positionKey":"0d7a1cf5-bdc2-40c6-8af1-6006ebf03471:LONG","positionKind":"LONG","marketValueUsd":"6691972","longBookWeight":"0.00396484","sharesPrincipal":{"type":"SH","amount":"725024"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"0d7a1cf5-bdc2-40c6-8af1-6006ebf03471","cusip":"014442107","issuerName":"ALECTOR INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"cca26477-6b9e-4d4f-91d4-1c9602fc9334","positionKey":"b192107f-0868-453f-8f05-b32b9b49e92f:LONG","positionKind":"LONG","marketValueUsd":"6545736","longBookWeight":"0.00387820","sharesPrincipal":{"type":"SH","amount":"914209"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"b192107f-0868-453f-8f05-b32b9b49e92f","cusip":"50015M109","issuerName":"KODIAK SCIENCES INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"8fec3bab-d166-4cdb-a055-8c1d7c01fae3","positionKey":"014d0054-bc82-4c59-8a51-fbeba7032be7:LONG","positionKind":"LONG","marketValueUsd":"6418750","longBookWeight":null,"sharesPrincipal":{"type":"PRN","amount":"6500000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"014d0054-bc82-4c59-8a51-fbeba7032be7","cusip":"868459AD0","issuerName":"SUPERNUS PHARMACEUTICALS","classTitle":"NOTE  0.625% 4/0","securityType":"DEBT","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"4f4eb4ba-1a94-41ec-a578-14ccfe66c1f2","positionKey":"1d95ca1a-29ec-43be-bb23-4e7baf2c1bd9:LONG","positionKind":"LONG","marketValueUsd":"6300000","longBookWeight":"0.00373260","sharesPrincipal":{"type":"SH","amount":"2000000"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"1d95ca1a-29ec-43be-bb23-4e7baf2c1bd9","cusip":"36118A100","issuerName":"FUSION PHARMACEUTICALS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"422dbaf2-79cc-4da1-81e4-05776af44d6d","positionKey":"f01cf453-4d51-4e28-b923-01d4c3d8c3dd:LONG","positionKind":"LONG","marketValueUsd":"4612802","longBookWeight":"0.00273298","sharesPrincipal":{"type":"SH","amount":"1164849"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"f01cf453-4d51-4e28-b923-01d4c3d8c3dd","cusip":"59935V107","issuerName":"MILESTONE PHARMACEUTICALS IN","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"708080b1-339c-44a8-91c9-702924c89ce8","positionKey":"f143ea20-735f-4d3d-b81d-c64590aba43d:LONG","positionKind":"LONG","marketValueUsd":"4001760","longBookWeight":null,"sharesPrincipal":{"type":"SH","amount":"381120"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"f143ea20-735f-4d3d-b81d-c64590aba43d","cusip":"61559X104","issuerName":"MOONLAKE IMMUNOTHERAPEUTICS","classTitle":"CLASS A ORD","securityType":"UNKNOWN","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"68f19410-67da-4704-8658-b5801539d6df","positionKey":"dd8f9c82-4865-4c27-a0dc-236cb3375af7:LONG","positionKind":"LONG","marketValueUsd":"2910816","longBookWeight":"0.00172459","sharesPrincipal":{"type":"SH","amount":"258280"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"dd8f9c82-4865-4c27-a0dc-236cb3375af7","cusip":"00166B105","issuerName":"ALX ONCOLOGY HLDGS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"9e45fdfd-6dfd-43e1-a277-5213dd07a9e6","positionKey":"a4de815a-176b-4178-94b8-15331001397e:LONG","positionKind":"LONG","marketValueUsd":"1401833","longBookWeight":"0.00083055","sharesPrincipal":{"type":"SH","amount":"620280"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"a4de815a-176b-4178-94b8-15331001397e","cusip":"640268108","issuerName":"NEKTAR THERAPEUTICS","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null},{"id":"20579028-5581-4622-aa4f-00632dcec204","positionKey":"1b459251-0ade-49f0-9212-c38c200e5b70:LONG","positionKind":"LONG","marketValueUsd":"1398055","longBookWeight":"0.00082831","sharesPrincipal":{"type":"SH","amount":"71585"},"comparison":{"status":"NOT_COMPARABLE"},"security":{"id":"1b459251-0ade-49f0-9212-c38c200e5b70","cusip":"46565G104","issuerName":"ITEOS THERAPEUTICS INC","classTitle":"COM","securityType":"COMMON_STOCK","mappingStatus":"PENDING"},"entity":null,"aiProjections":[],"currentMarketData":null}]}}